These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of immobilization, cold and cold-restraint stress on liver monooxygenase activity and lipid peroxidation of influenza virus-infected mice. Mileva M; Bakalova R; Tancheva L; Galabov S Arch Toxicol; 2002 Mar; 76(2):96-103. PubMed ID: 11914779 [TBL] [Abstract][Full Text] [Related]
3. [Dynamics of peroxidation of brain tissue lipids in mice infected with influenza virus in the presence of immobilization stress]. Misheneva MS; Chetverikova LK; Frolov BA Mol Gen Mikrobiol Virusol; 1988 Feb; (2):45-8. PubMed ID: 2836724 [TBL] [Abstract][Full Text] [Related]
4. [Post-stress disorders of resistance of mice to recurrent infection by homologous influenza virus]. Kramskaia TA; Chetverikova LK; Frolova BA; Poliak RIa Vestn Akad Med Nauk SSSR; 1991; (4):47-50. PubMed ID: 1866988 [TBL] [Abstract][Full Text] [Related]
5. [Possibility of viral penetration into the brain during influenza against a background of stress (experimental study)]. Chetverikova LK; Frolov BA; Kramskaia TA; Poliak RIa Fiziol Cheloveka; 1987; 13(3):482-5. PubMed ID: 3609578 [No Abstract] [Full Text] [Related]
6. Significance of long lasting persistence of influenza virus antigens at the portal of infection and in the spleen of mice. Dubrovina TYa ; Ivanova IA; Shidlovskaya NK; Polyak RYa Acta Virol; 1992 Oct; 36(5):450-8. PubMed ID: 1364021 [TBL] [Abstract][Full Text] [Related]
7. Interferon and humoral immune response in experimental influenza: infection with A/PR8 virus adapted to the mouse. LobodziĆska M; Albin M Arch Immunol Ther Exp (Warsz); 1980; 28(2):323-8. PubMed ID: 6160829 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of prophylactic administration of epsilon-amino caproic acid during influenza in mice. Puzis LE; Lozitsky VP; Polyak RYa Acta Virol; 1986 Jan; 30(1):58-62. PubMed ID: 2871734 [TBL] [Abstract][Full Text] [Related]
9. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Kreijtz JH; Bodewes R; van Amerongen G; Kuiken T; Fouchier RA; Osterhaus AD; Rimmelzwaan GF Vaccine; 2007 Jan; 25(4):612-20. PubMed ID: 17005299 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic effects of chitin microparticles on highly pathogenic H5N1 influenza virus. Ichinohe T; Nagata N; Strong P; Tamura S; Takahashi H; Ninomiya A; Imai M; Odagiri T; Tashiro M; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H J Med Virol; 2007 Jun; 79(6):811-9. PubMed ID: 17457919 [TBL] [Abstract][Full Text] [Related]
12. [Factors of antiviral resistance in the pathogenesis of influenza in mice]. Chetverikova LK; Ki'ldivatov IIu; Inozemtseva LI; Kramskaia TA; Filippov VK; Frolov BA Vestn Akad Med Nauk SSSR; 1989; (11):63-8. PubMed ID: 2623936 [TBL] [Abstract][Full Text] [Related]
13. Effect on influenza virus infection on the production of interferon by alveolar and peritoneal cells in vitro. Szulc B; Szalaty H Arch Immunol Ther Exp (Warsz); 1980; 28(1):93-7. PubMed ID: 6158300 [TBL] [Abstract][Full Text] [Related]
14. [Effect of fenazepam on the ACTH content of the blood plasma in inbred mice under stress exposure]. Seredenin SB; Blednov IuA Biull Eksp Biol Med; 1986 Dec; 102(12):724-6. PubMed ID: 3026513 [TBL] [Abstract][Full Text] [Related]
15. Interferon production and infection caused by influenza virus in radiation chimeras. Mentkevich LM; Orlova TG; Shcheglovitova ON Acta Virol; 1973 Sep; 17(5):435-8. PubMed ID: 4148117 [No Abstract] [Full Text] [Related]
16. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection. Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010 [TBL] [Abstract][Full Text] [Related]
17. Peculiarities of influenza infection caused by highly and poorly immunogenic strains of influenza virus. Frolov AF; Skripchenko GS; Shcherbinskaya AM; Vlasova AG; Rybakova TM J Hyg Epidemiol Microbiol Immunol; 1984; 29(3):303-9. PubMed ID: 6544322 [TBL] [Abstract][Full Text] [Related]
18. Cascade of fever production in mice infected with influenza virus. Kurokawa M; Imakita M; Kumeda CA; Shiraki K J Med Virol; 1996 Oct; 50(2):152-8. PubMed ID: 8915881 [TBL] [Abstract][Full Text] [Related]
19. Protection from lethal influenza virus challenge by oral type 1 interferon. Beilharz MW; Cummins JM; Bennett AL Biochem Biophys Res Commun; 2007 Apr; 355(3):740-4. PubMed ID: 17316562 [TBL] [Abstract][Full Text] [Related]
20. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]